Orthobiologics in foot and ankle surgery

Journal of the American Academy of Orthopaedic Surgeons

Volumn 24, Issue 2, 2016, Pages 113-122

  Lin, Sheldon S ^a   Montemurro, Nicholas J ^a   Krell, Ethan S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

bone morphogenetic proteins (BMPs); foot and ankle; orthobiologics; platelet derived growth factor (PDGF); platelet rich plasma (PRP)

Indexed keywords

BONE MORPHOGENETIC PROTEIN; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR;

ACHILLES TENDON; ANKLE; BONE REGENERATION; DRUG EFFECTS; FOOT; HUMAN; ORTHOPEDIC SURGERY; PROCEDURES; SURGERY; TENDINOPATHY; THROMBOCYTE RICH PLASMA; WOUND HEALING;

ACHILLES TENDON; ANKLE; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; FOOT; HUMANS; ORTHOPEDIC PROCEDURES; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; TENDINOPATHY; WOUND HEALING;

EID: 84955614722     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/JAAOS-D-14-00155     Document Type: Review

References (34)

1. Kagel EM, Einhorn TA. Alterations of fracture healing in the diabetic condition. Iowa Orthop J. 1996; 16: 147-152.
2. Mehta SK, Breitbart EA, Berberian WS, Liporace FA, Lin SS. Bone and wound healing in the diabetic patient. Foot Ankle Clin. 2010; 15(3): 411-437.
3. Daniels T, DiGiovanni C, Lau JT, Wing K, Younger A. Prospective clinical pilot trial in a single cohort group of rhPDGF in foot arthrodeses. Foot Ankle Int. 2010; 31(6): 473-479.
4. DiGiovanni CW, Baumhauer J, Lin SS, et al. Prospective, randomized, multi-center feasibility trial of rhPDGF-BB versus autologous bone graft in a foot and ankle fusion model. Foot Ankle Int. 2011; 32(4): 344-354.
5. DiGiovanni CW, Lin SS, Baumhauer JF, et al; North American Orthopedic Foot and Ankle Study Group: Recombinant human platelet-derived growth factor-BB and betatricalcium phosphate (rhPDGF-BB/.b-TCP): An alternative to autogenous bone graft. J Bone Joint Surg Am. 2013; 95(13): 1184-1192.
6. Bibbo C, Patel DV, Haskell MD. Recombinant bone morphogenetic protein-2 (rhBMP-2) in high-risk ankle and hindfoot fusions. Foot Ankle Int. 2009; 30 (7): 597-603.
7. DeVries JG, Nguyen M, Berlet GC, Hyer CF. The effect of recombinant bone morphogenetic protein-2 in revision tibiotalocalcaneal arthrodesis: Utilization of the Retrograde Arthrodesis Intramedullary Nail database. J Foot Ankle Surg. 2012; 51(4): 426-432.
8. Fourman MS, Borst EW, Bogner E, Rozbruch SR, Fragomen AT. Recombinant human BMP-2 increases the incidence and rate of healing in complex ankle arthrodesis. Clin Orthop Relat Res. 2014; 472(2): 732-739.
9. Schuberth JM, DiDomenico LA, Mendicino RW. The utility and effectiveness of bone morphogenetic protein in foot and ankle surgery. J Foot Ankle Surg. 2009; 48(3): 309-314.
10. Wei LC, Lei GH, Sheng PY, et al. Efficacy of platelet-rich plasma combined with allograft bone in the management of displaced intra-Articular calcaneal fractures: A prospective cohort study. J Orthop Res. 2012; 30(10): 1570-1576.
11. Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M. Plateletrich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med. 2012; 40(3): 534-541.
12. Guney A, Akar M, Karaman I, Oner M, Guney B. Clinical outcomes of platelet rich plasma (PRP) as an adjunct to microfracture surgery in osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc. 2015; 23(8): 2384-2389.
13. de Vos RJ, Weir A, van Schie HT, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA. 2010; 303(2): 144-149.
14. de Jonge S, de Vos RJ, Weir A, et al. Oneyear follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: A double-blind randomized placebocontrolled trial. Am J Sports Med. 2011; 39 (8): 1623-1629.
15. Akşahin E, Dogruyol D, Yüksel HY, et al. The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis. Arch Orthop Trauma Surg. 2012; 132(6): 781-785.
16. Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc. 2006; 81(9): 1241-1257.
17. Hollinger JO, Hart CE, Hirsch SN, Lynch S, Friedlaender GE. Recombinant human platelet-derived growth factor: Biology and clinical applications. J Bone Joint Surg Am. 2008; 90(Suppl 1): 48-54.
18. Easley ME, Trnka HJ, Schon LC, Myerson MS. Isolated subtalar arthrodesis. J Bone Joint Surg Am. 2000; 82(5): 613-624.
19. Frey C, Halikus NM, Vu-Rose T, Ebramzadeh E A review of ankle arthrodesis: Predisposing factors to nonunion. Foot Ankle Int. 1994; 15(11): 581-584.
20. Haddad SL, Coetzee JC, Estok R, Fahrbach K, Banel D, Nalysnyk L. Intermediate and long-Term outcomes of total ankle arthroplasty and ankle arthrodesis: A systematic review of the literature. J Bone Joint Surg Am. 2007; 89 (9): 1899-1905.
21. Regranex® Gel Product Information, May 2008. Ortho-McNeil, Raritan NJ 08869. http://www.fda.gov/downloads/Drugs/.DrugSafety/PostmarketDrugSafety InformationforPatientsandProviders/.UCM142821.pdf (Accessed 11/29/14).
22. Ziyadeh N, Fife D, Walker AM, Wilkinson GS, Seeger JD A matched cohort study of the risk of cancer in users of becaplermin. Adv Skin Wound Care. 2011; 24(1): 31-39.
23. Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev. 1994; 4(5): 737-744.
24. Coughlin MJ, Grimes JS, Traughber PD, Jones CP. Comparison of radiographs and CT scans in the prospective evaluation of the fusion of hindfoot arthrodesis. Foot Ankle Int. 2006; 27(10): 780-787.
25. Kanakaris NK, Mallina R, Calori GM, Kontakis G, Giannoudis PV. Use of bone morphogenetic proteins in arthrodesis: Clinical results. Injury. 2009; 40(Suppl 3): S62-S66.
26. Wysocki RW, Cohen MS. Ectopic ossification of the triceps muscle after application of bone morphogenetic protein-7 to the distal humerus for recalcitrant nonunion: A case report. J Hand Surg Am. 2007; 32(5): 647-650.
27. Boraiah S, Paul O, Hawkes D, Wickham M, Lorich DG. Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: A preliminary report. Clin Orthop Relat Res. 2009; 467(12): 3257-3262.
28. Paramore CG, Lauryssen C, Rauzzino MJ, et al. The safety of OP-1 for lumbar fusion with decompression: A canine study. Neurosurgery. 1999; 44(5): 1151-1155.
29. Epstein NE. Complications due to the use of BMP/INFUSE in spine surgery: The evidence continues to mount. Surg Neurol Int. 2013; 4(Suppl 5): S343-S352.
30. Dahabreh Z, Calori GM, Kanakaris NK, Nikolaou VS, Giannoudis PV A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7. Int Orthop. 2009; 33(5): 1407-1414.
31. Alt V, Donell ST, Chhabra A, Bentley A, Eicher A, Schnettler R A health economic analysis of the use of rhBMP-2 in Gustilo-Anderson grade III open tibial fractures for the UK, Germany, and France. Injury. 2009; 40(12): 1269-1275.
32. Alsousou J, ThompsonM,Hulley P,NobleA, Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: A review of the literature. J Bone Joint Surg Br. 2009; 91(8): 987-996.
33. Gandhi A, Bibbo C, Pinzur M, Lin SS. The role of platelet-rich plasma in foot and ankle surgery. Foot Ankle Clin. 2005; 10(4, viii)621-637, viii
34. Monto RR. Platelet rich plasma treatment for chronic Achilles tendinosis. Foot Ankle Int. 2012; 33(5): 379-385.